Anxiety Disorders
📧 Sign up to get email alerts when something new happens for Anxiety Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Retrospective Medical Record Review of Mind Body Depression Group Participants
Retrospective medical record review of participants in a Mind-Body Depression group, reporting outcomes from the completed study.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Life Satisfaction and Psychopathology in Institutionalized Elderly People [NA]
A completed clinical trial examining life satisfaction and psychopathology among institutionalized elderly people with mild or non-persisten…
-
CLINICAL_TRIALS research · 2016-05-12Clinical Trial Update: Investigating the Effects of Parent Component to Cognitive Behavior Therapy (CBT) for Youth With Anxiety Disorders [NA]
This document describes a clinical trial evaluating whether adding a parent component to cognitive behavioral therapy improves outcomes for …
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges [NA]
A completed trial evaluated Manville Moves, an exercise intervention aimed at improving behavioral regulation in children with behavioral he…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)
A completed clinical trial from Washington University School of Medicine investigating mood mapping in the subthalamic nucleus for Parkinson…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-05-02FDA Approved: DIAZEPAM INTENSOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Diazepam Intensol from Hikma Pharmaceuticals USA Inc., confirming changes to the approved pr…
-
CLINICAL_TRIALS research · 2016-05-02Clinical Trial Update: Short- and Long-term Group Psychotherapy [Phase 2]
Phase 2 clinical trial update from the University of Oslo on short- and long-term group psychotherapy for mood and anxiety disorders (includ…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: A Parent-only Group Cognitive Behavioral Intervention for Children With Anxiety Disorders: a Control Group Study [NA]
Completed clinical trial evaluating a parent-only group cognitive behavioral intervention for children with anxiety disorders, using a contr…
-
FDA approval · 2016-04-25FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental ANDA for a generic chlordiazepoxide and amitriptyline hydrochloride tablet by Mylan Pharmaceuticals.
-
FDA approval · 2016-04-18FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lorazepam from Hikma Pharmaceuticals USA Inc., indicating an approved update to the drug's l…
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: A Comparison of Two Doses of Intranasal Dexmedetomidine for Premedication in Children [Phase 4]
Phase 4 clinical trial update comparing two doses of intranasal dexmedetomidine used as premedication in pediatric patients.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care [NA]
A trial evaluating Brief Cognitive Behavioral Therapy for pediatric anxiety and depression in primary care has completed. The study was spon…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: Unified Cognitive-Behavioral Therapy (CBT) vs. Combined CBT and Dance/Movement Therapy (DMT) for Anxiety Disorders [NA]
A clinical trial comparing Unified Cognitive-Behavioral Therapy (CBT) with a combined CBT and Dance/Movement Therapy (DMT) approach for anxi…
-
CLINICAL_TRIALS research · 2016-04-13Clinical Trial Update: Low Field Magnetic Stimulation: Open Label Study. [Phase 1, Phase 2]
Open-label Phase 1/2 trial evaluating the use of Low Field Magnetic Stimulation for mood disorders and anxiety.
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: VA Home-Based Emotional Learning With Practical Skills [NA]
Completed clinical trial of a home-based emotional learning program for anxiety and depression.
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxyzine hydrochloride by Teva Pharmaceuticals USA, Inc., under ANDA088617.
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals' supplemental application for hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) under ANDA 040808. T…
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) from Chartwell RX, LLC. This approval allo…
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (American Regent, Inc.)
The FDA approved a supplemental application for hydroxyzine hydrochloride from American Regent, Inc., finalizing an update to the generic pr…
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxyzine hydrochloride (generic) from Aurobindo Pharma Limited, expanding approval of a gener…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity [Phase 2]
Phase 2 clinical trial evaluating an anxiety sensitivity-based intervention for co-occurring substance use disorders and anxiety has complet…
-
FDA approval · 2016-03-24FDA Approved: DIAZEPAM — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application to Chartwell RX, LLC for diazepam oral solution (concentrate), authorizing a generic version of this…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Return to Work: Promoting Health and Productivity in Workers With Common Mental Disorders [NA]
This document reports the completion of a clinical trial evaluating a return-to-work intervention for workers with common mental disorders, …
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Maternal Singing During Kangaroo Care in Preterm Infants [NA]
A completed clinical trial examined whether maternal singing during kangaroo care influences outcomes for preterm infants and maternal anxie…
-
CLINICAL_TRIALS research · 2016-03-11Clinical Trial Update: Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders
A completed clinical study from Rhode Island Hospital evaluated how parenting styles and child temperament relate to anxiety disorders and o…